New drug targets tough esophageal cancer in early trial
NCT ID NCT07405151
First seen Feb 15, 2026 · Last updated May 05, 2026 · Updated 6 times
Summary
This study tests a drug called I-DXd in people with advanced esophageal cancer that has not responded to prior treatments. I-DXd is designed to attach to cancer cells and deliver a powerful treatment directly to them. The main goal is to see how many participants have their tumors shrink or disappear. About 60 adults with this type of cancer will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OESOPHAGEAL SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Aichi Cancer Center ( Site 2702)
RECRUITINGNagoya, Aichi-ken, 464-8681, Japan
Contact Phone: •••-•••-••••
-
Asan Medical Center ( Site 2901)
RECRUITINGSeoul, 05505, South Korea
Contact Phone: •••-•••-••••
-
Hopitaux Universitaires de Geneve HUG ( Site 3701)
RECRUITINGGeneva, 1211, Switzerland
Contact Phone: •••-•••-••••
-
Kanagawa Cancer Center ( Site 2701)
RECRUITINGYokohama, Kanagawa, 241-8515, Japan
Contact Phone: •••-•••-••••
-
National Cancer Center Hospital ( Site 2700)
RECRUITINGChūō, Tokyo, 104-0045, Japan
Contact Phone: •••-•••-••••
-
National Cheng Kung University Hospital ( Site 3001)
RECRUITINGTainan, 704, Taiwan
Contact Phone: •••-•••-••••
-
Samsung Medical Center ( Site 2900)
RECRUITINGSeoul, 06351, South Korea
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.